Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

BENZTROPINE MESYLATE Drug Profile

« Back to Dashboard

Which patents cover Benztropine Mesylate, and when can generics launch?

Benztropine Mesylate is a drug marketed by Upsher-smith Labs, Oxford Pharms, Quantum Pharmics, Usl Pharma, Aspen Global Inc, Vintage, Navinta Llc, Fresenius Kabi Usa, Luitpold, Pliva, Corepharma, Frontida Biopharm, Leading Pharma Llc, Lannett Holdings Inc, Hikma Farmaceutica, and Invagen Pharms. and is included in twenty-nine NDAs.

The generic ingredient in BENZTROPINE MESYLATE is benztropine mesylate. There are five drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

Summary for Tradename: BENZTROPINE MESYLATE

Patents:0
Applicants:16
NDAs:29
Suppliers / Packagers: see list32
Bulk Api Vendors: see list62
Clinical Trials: see list180
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BENZTROPINE MESYLATE at DailyMed

Pharmacology for Tradename: BENZTROPINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Holdings Inc
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL088877-001Apr 11, 1985DISCNNoNo► Subscribe► Subscribe
Corepharma
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL072266-001Feb 27, 1989AARXNoNo► Subscribe► Subscribe
Hikma Farmaceutica
BENZTROPINE MESYLATE
benztropine mesylate
INJECTABLE;INJECTION090287-001Aug 31, 2009APRXNoNo► Subscribe► Subscribe
Leading Pharma Llc
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL090168-001Nov 28, 2012AARXNoNo► Subscribe► Subscribe
Upsher-smith Labs
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL040103-001Dec 12, 1996AARXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot